Be careful out there, don't stop taking statins without your doctors approval. 30% or 87%? But is it statins or the underlying disease that causes your doctor to prescribe statins? Your doctor should have warned you about this and be monitoring your condition since May 2015;
In a database study of nearly 26,000 beneficiaries of Tricare, the military health system, those taking statin drugs to control their cholesterol were 87 percent more likely to develop diabetes.
Or is your doctor using coffee to try to prevent diabetes? Making the assumption that it will translate from mice to humans.
Substance in coffee delays onset of diabetes in laboratory mice
Your doctor can also consider this:
High-intensity statin therapy alters the progressive nature of diabetic coronary atherosclerosis, yielding regression of disease in diabetic and nondiabetic patients.
Taking statins raises the risk of Type 2 diabetes by nearly a third: Findings reopens debate about the pills benefits and side effects
- Six million Britons take the pills every day to fight cholesterol and heard disease
- Study tracked overweight people already at risk of diabetes who take statins
- Decade-long study found them 30 per cent more likely to develop condition
Taking statins increases the risk of type 2 diabetes by nearly a third, researchers found.
A
decade-long study of more than 3,200 patients found those who took
statins were 30 per cent more likely to develop the condition.
Some six million Britons take statins every day to reduce their cholesterol and ward off heart disease.
The
pills are proven lifesavers, slashing the chance of a repeat attack,
yet a scientific row over benefits and side effects has dragged on for
years.A study of more than 3,200 patients found people taking statins are 30 per cent more likely to develop type 2 diabetes
Experts
have long known there was a link between statins and diabetes – but
doctors have always stressed that the advantages of the pills far
outweigh the small chance of getting diabetes.
Previous research had put the chance
of developing type 2 diabetes at no more than 10 to 12 per cent greater
than if someone did not take statins. The latest study, however,
suggests the medication increases the risk by 30 per cent.
The
researchers, from Albert Einstein College of Medicine in New York,
think this may be because statins impair insulin production. In the
journal BMJ Open Diabetes Research & Care, they called for regular
blood sugar tests of people taking statins.
‘Glucose status should be
monitored and healthy lifestyle behaviours reinforced in high-risk
patients who are prescribed statins for cardiovascular disease
[prevention],’ they wrote.
The
scientists tracked overweight people already considered at risk of
diabetes for ten years. At the start, 4 per cent took statins, but by
the end roughly a third were taking the pills.
No link was found between the potency of the statins used and diabetes risk.
Statins have been shown to significantly reduce the risk of heart attacks and strokes
The
researchers stressed that the additional risk of developing diabetes
should be balanced against ‘the consistent and highly significant’
reduction in risk of heart attacks, strokes and death. Last night
experts said that although the relative risk of diabetes may seem high,
in reality the absolute numbers of people it would affect would be
small.
The New York researchers did not
include absolute numbers in their study. But Dr Tim Chico, consultant
cardiologist at Sheffield University, estimated the findings would mean
an increase in risk from roughly 0.16 per cent to roughly 0.2 per cent.
‘This
study further confirms that there is a small increase in risk of
diabetes with statin treatment,’ Dr Chico said. But he added: ‘Type 2
diabetes is largely caused by being overweight, and having a poor diet
and a sedentary lifestyle, and more attention must be directed to
addressing these.’
Pav Kalsi, of
Diabetes UK, said: ‘Statins can significantly reduce risk of heart
attacks and strokes, so it is important that people who have been
prescribed statins continue to take their medication.’
Professor
Stephen O’Rahilly of Cambridge University, said the study ‘relies on
modelling to take into account confounding factors underlying the
reasons for prescribing statins … Therefore, these results cannot be
viewed as definitive’
No comments:
Post a Comment